Chloroquine Phosphate
Malaria
CommercialActive
Key Facts
About Ipca Laboratories
Ipca Laboratories Ltd. is a prominent, fully integrated Indian pharmaceutical company with a significant global footprint in over 120 countries. Its core strengths lie in its vertical integration, from API manufacturing to finished formulations, particularly in therapeutic segments like anti-malarials, NSAIDs, and anti-diabetics. The company has a diversified business model spanning domestic formulations, international branded generics, and API exports, and is strategically focused on expanding its presence in regulated markets like the US while navigating complex regulatory landscapes.
View full company profileTherapeutic Areas
Other Malaria Drugs
| Drug | Company | Phase |
|---|---|---|
| Malaria Vaccine (R21/Matrix-M) | Novavax | Phase 3 |
| Anti-malarial Portfolio | Strides Pharma | Approved |
| STANDARD Q Malaria Pf/Pan Ag Test | SD BioSensor | Approved |
| Anti-malarial Portfolio (ACTs) | Bliss GVS Pharma | Approved |